Transoral robotic supraglottic laryngectomy: Long-term functional and oncologic outcomes

Objectives: Minimally invasive transoral organ preservation surgeries are being increasingly used for supraglottic tumors. This study investigates the long-term functional and oncologic outcomes of transoral robotic supraglottic laryngectomy (TORS-SGL).Materials and methods: Twenty-three patients with supraglottic laryngeal cancer who underwent TORS-SGL be-tween 2012 and 2015 at a tertiary referral hospital were retrospectively analyzed with at least 5 years of follow-up. The head and neck tumor council and the multidisciplinary oncological board decided whether the patients were suitable for robotic surgery, and the necessity of adjuvant radiotherapy or chemotherapy. Inclusion criteria was histopathological diagnosis of squamous cell carcinoma of the larynx.Results: Twenty-one patients with T1-T3 supraglottic squamous cell carcinoma were included in this study. Mean follow-up was 48.8 months. Local control was 94.4 % at 2 years and 85.9 % at 5 years. Disease-free survival and overall survival were 85.7 % and 81 % at 2 years and 69.3 % and 57.1 % at 5 years, respectively. There was no permanent tracheostomy or prolonged swallowing dysfunction among patients. Age, perineural and lympho-vascular invasion were found to be risk factors affecting overall survival.Conclusion: TORS-SGL is a feasible, safe and reliable approach with excellent functional results for T1, T2, and selected T3 supraglottic tumors, providing acceptable long-term oncologic results when compared to alternative treatment modalities.

Automated summary

This study investigated the long-term functional and oncologic outcomes of transoral robotic supraglottic laryngectomy (TORS-SGL). The results showed that TORS-SGL has excellent functional results for T1, T2, and selected T3 supraglottic tumors, and provides acceptable long-term oncologic results compared to alternative treatment modalities.